Atherectomy Devices Industry Overview
Plaque and atherosclerosis are removed from the body's blood vessels during a surgical procedure known as an atherectomy using a catheter equipped with a cutting blade. It is essentially a minimally invasive endovascular surgical procedure helped by local anesthesia. In order to produce a sizable channel and help restore blood flow in the arteries, atherectomy involves removing plaque and hardened lesions from the artery. They are widely used in cardiovascular, neurovascular, and peripheral applications.The use of minimally invasive surgery (MIS) is growing in popularity. These methods result in less trauma for the patient and a speedier recovery than intrusive procedures. The possibility of infection from intrusive procedures is another reason behind this decision. Since atherectomy is a minimally invasive technique, the growing desire for less invasive operations will have a major impact on the market's expected growth.
Growth Drivers of Atherectomy Devices Market
Increasing Preference for Less Invasive Surgical Procedures, Growing Prevalence of Diseases and the Aging Population, and Improved Success RateThe market for atherectomy devices is driven by the increasing incidence of cardiovascular illnesses, the aging population, and the shift toward less invasive procedures. Globally, atherosclerosis and other cardiovascular diseases are the main causes of illness and death. 2.6 million people in the UK suffer constriction of the cardiac arteries, which can lead to angina or heart attacks. According to estimates from the American Heart Association, coronary artery disease - the leading cause of death in the US - affects 16 million Americans. Because aging-related changes in vascular fitness increase the risk of various diseases in the aging population. The need for atherectomy devices is driven by the aging population.
The adoption of atherectomy operations by healthcare professionals and clinicians has been prompted by technological developments in atherectomy equipment, which have made the treatments safer and more successful. The need for atherectomy treatments is rising because to increased knowledge and diagnostic skills. Healthcare practitioners can now propose suitable interventions when atherosclerotic lesions are promptly detected and accurately diagnosed. All things considered, these variables fuel the rising demand for atherectomy surgeries as a successful atherosclerosis treatment option, spurring advancements in device technology.
An increase in cases of peripheral artery disease (PAD)
The aging population, rising rates of diabetes, and an increase in obesity have all contributed to an increase in PAD cases, which has led to an expansion in the global atherectomy device market. Eight to twelve million Americans suffer from PAD, mostly in their 50s. 6.5 million of them are above 40 and have been diagnosed with PAD. With atherectomy devices, arterial plaque can be removed with little invasiveness, making them a valuable choice in vascular treatments. This device reduces fatigue and leg pain while also increasing blood flow. By instantly eliminating or vaporizing the plaque, these devices can restore arterial patency, which significantly improves patient outcomes for people with severe PAD.
North America Atherectomy Devices Market
The market is anticipated to be dominated by North America. The growing patient population with peripheral and coronary artery diseases, the growing number of clinical trials (which assess the therapeutic efficacy of atherectomy systems in treating particular diseases), the growing availability of reimbursements for atherectomy systems, and the adoption of atherectomy systems by medical professionals are all contributing factors to the growth of the atherectomy devices market in North America.According to the CDC's February 2022 report, heart disease is the top cause of death in the United States, regardless of gender, race, or ethnicity. Heart disease most commonly occurs from coronary heart disease (CHD), also called coronary artery disease. It is defined by the build-up of cholesterol blockages in the coronary artery walls or by an excessive narrowing of the coronary arteries. The development of these blockages can result in a heart attack or stroke. Because heart diseases are becoming more common, there will likely be a greater need for atherectomy treatments in the region. This will likely drive expansion in the market under analysis during the projected period.
A huge variety of FDA-approved devices and a suitable reimbursement framework are also major contributors to this dominance. For example, Becton, Dickinson, and Company (BD) announced in October 2021 that the U.S. FDA had approved their 510(k) application for more indications for the Rotarex Atherectomy System.
Atherectomy Devices Company Analysis
The leading companies in the atherectomy devices market are AngioDynamics Inc., Terumo Corporation, Integer Holdings Corporation, Boston Scientific Corporation, Inc., Abbott Laboratories, Medtronic plc, Cardinal Health, and Becton, Dickinson and Company.Atherectomy Devices Company News
- In November 2023, Cardinal Health announced the debut of their SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets in the United States to provide surgical teams with safe and useful instrument access in the operating room.
- In June 2023, The FDA has approved Pantheris LV, a next-generation image-guided atherectomy device developed by Avinger, Inc. to treat peripheral artery disease (PAD). The system has new features such improved torque feedback, plaque apposition design, and faster cutter rates. By the end of the quarter, it will be introduced in restricted quantities, and in the second half of 2023, it will be made fully available for purchase. With no ionizing radiation exposure, treatment is guided by optical coherence tomography (OCT) pictures with Avinger's Lumivascular technology, guaranteeing safe and successful results.
- In February 2023, Cardiovascular Systems, a well-known manufacturer of medical devices noted for its innovative atherectomy system intended to treat peripheral and coronary artery disease, was purchased by Abbott. A monetary payment of $20 per common share will be given to CSI investors as per the terms of the agreement; this will raise the expected equity value to $890 million. Regarding atherectomy devices, CSI is one of the leading companies in the business. These tools are intended to maximize the benefits of conventional balloon angioplasty and stent therapies, especially when complex vascular disorders are involved. Abbott's portfolio of vascular devices will be improved by the acquisition by adding complementary technology.
Product Type - Market breakup in 4 viewpoints:
- Directional Atherectomy
- Rotational Atherectomy
- Orbital Atherectomy
- Laser Atherectomy
Application - Market breakup in 3 viewpoints:
- Cardiovascular
- Neurovascular
- Peripheral Vascular
End User - Market breakup in 3 viewpoints:
- Hospitals
- Ambulatory Care Service
- Medical Research Institutes
Countries - Market breakup in 26 viewpoints:
North America
- United States
- Canada
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherland
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Indonesia
- New Zealand
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
- UAE
Rest of the World
The key players have been covered from 4 viewpoints:
- Business Overview
- Key Persons
- Recent Development
- Financial Insights
Key Players Analysis:
- Boston Scientific Corporation, Inc.
- Abbott Laboratories
- Medtronic plc
- Cardinal Health
- Terumo Corporation
- Integer Holdings Corporation
- Becton, Dickinson and Company
Table of Contents
Companies Mentioned
- Boston Scientific Corporation, Inc.
- Abbott Laboratories
- Medtronic plc
- Cardinal Health
- Terumo Corporation
- Integer Holdings Corporation
- Becton, Dickinson and Company
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | August 2024 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 964.3 Million |
Forecasted Market Value ( USD | $ 2028.3 Million |
Compound Annual Growth Rate | 8.6% |
Regions Covered | Global |
No. of Companies Mentioned | 7 |